Abstract | BACKGROUND: METHODS: During a multicenter survey of Enterobacteriaceae causing UTIs in outpatients during 2005-2007, Cefditoren MICs were determined by agar dilution method in a randomly selected sample of uropathogens. Susceptibility against 18 other oral/parenteral antimicrobials was determined according to Clinical and Laboratory Standards Institute methodology. RESULTS: CONCLUSIONS:
Cefditoren exhibited enhanced in vitro activity against the most common uropathogens in the outpatient setting, representing an alternative oral treatment option in patients with risk factors for resistance to first-line antibiotics.
|
Authors | Despina Hatzaki, Garyphallia Poulakou, Ioannis Katsarolis, Niki Lambri, Maria Souli, Ioannis Deliolanis, Georgios K Nikolopoulos, Evangelia Lebessi, Helen Giamarellou |
Journal | BMC infectious diseases
(BMC Infect Dis)
Vol. 12
Pg. 228
(Sep 25 2012)
ISSN: 1471-2334 [Electronic] England |
PMID | 23009290
(Publication Type: Journal Article, Multicenter Study)
|
Chemical References |
- Anti-Bacterial Agents
- Cephalosporins
- cefditoren
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
(therapeutic use)
- Cephalosporins
(therapeutic use)
- Drug Resistance, Bacterial
- Enterobacteriaceae
(drug effects, isolation & purification)
- Enterobacteriaceae Infections
(drug therapy, microbiology)
- Female
- Greece
- Humans
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Outpatients
- Pregnancy
- Risk Factors
- Treatment Outcome
- Urinary Tract Infections
(drug therapy, microbiology)
- Young Adult
|